Search Results - "McCulloch, Tine" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma

NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma

by Haakensen, Vilde Drageset, Nowak, Anna K, Ellingsen, Espen Basmo, Farooqi, Saima Jamil, Bjaanaes, Maria Moksnes, Horndalsveen, Henrik, Mcculloch, Tine, Grundberg, Oscar, Cedres, Susana M, Helland, Ãslaug
Published in Journal of translational medicine (31.05.2021)

Get full text

Journal Article

High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis

High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis

by Szejniuk, Weronika Maria, Nielsen, Martin Skovmos, Takács-Szabó, Zsuzsanna, Pawlowski, Jacek, Al-Saadi, Sahar Sulaiman, Maidas, Panagiotis, Bøgsted, Martin, McCulloch, Tine, Frøkjær, Jens Brøndum, Falkmer, Ursula Gerda, Røe, Oluf Dimitri
Published in Radiation oncology (London, England) (15.07.2021)

Get full text

Journal Article

Prospectively scored pulmonary toxicities in non-small cell lung cancer: Results from a randomized phase II dose escalation trial

Prospectively scored pulmonary toxicities in non-small cell lung cancer: Results from a randomized phase II dose escalation trial

by Lutz, Christina M., Knap, Marianne M., Hoffmann, Lone, Møller, Ditte S., Hansen, Olfred, Brink, Carsten, Schytte, Tine, Nyhus, Christa H., McCulloch, Tine, Borissova, Svetlana, Alber, Markus, Khalil, Azza A.
Published in Clinical and translational radiation oncology (01.03.2021)

Get full text

Journal Article

Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epidermal growth factor receptor mutated non-small cell lung cancer

Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epidermal growth factor receptor mutated non-small cell lung cancer

by Ebert, Eva Boysen Fynboe, McCulloch, Tine, Hansen, Karin Holmskov, Linnet, Hanne, Sorensen, Boe, Meldgaard, Peter
Published in Lung cancer (Amsterdam, Netherlands) (01.03.2020)

Get full text

Journal Article

Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients

Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients

by Boysen Fynboe Ebert, Eva, McCulloch, Tine, Holmskov Hansen, Karin, Linnet, Hanne, Sorensen, Boe, Meldgaard, Peter
Published in Lung cancer (Amsterdam, Netherlands) (01.05.2020)

Get full text

Journal Article

Genomic Profiling of Circulating Tumor DNA Predicts Outcome and Demonstrates Tumor Evolution in ALK-Positive Non-Small Cell Lung Cancer Patients

Genomic Profiling of Circulating Tumor DNA Predicts Outcome and Demonstrates Tumor Evolution in ALK-Positive Non-Small Cell Lung Cancer Patients

by Madsen, Anne Tranberg, Winther-Larsen, Anne, McCulloch, Tine, Meldgaard, Peter, Sorensen, Boe Sandahl
Published in Cancers (11.04.2020)

Get full text

Journal Article

Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art

Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art

by Szejniuk, Weronika Maria, Robles, Ana I., McCulloch, Tine, Falkmer, Ursula Gerda Inge, Røe, Oluf Dimitri
Published in The pharmacogenomics journal (01.02.2019)

Get full text

Journal Article

Remote symptom-monitoring of patients with advanced lung cancer: A Danish national randomized controlled trial—The ProWide study

Remote symptom-monitoring of patients with advanced lung cancer: A Danish national randomized controlled trial—The ProWide study

by Friis, Rasmus Blechingberg, Pappot, Helle, Hjøllund, Niels Henrik, McCulloch, Tine, Ingerslev Holt, Marianne, Persson, Gitte, Wedervang, Kim, Martini Clausen, Malene, Wahlstrøm, Stine, Holmskov Hansen, Karin, Rasmussen, Torben Riis, Dalton, Susanne Oksbjerg, Jakobsen, Erik, Linnet, Hanne, Skuladottir, Halla
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan

Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan

by Mau-Sørensen, Morten, Gerner-Rasmussen, Jonas, Hansen, Olfred, Holm, Bente, Nyhus, Christa Haugaard, McCulloch, Tine, Nielsen, Henrik Anker, Wedervang, Kim, Rytter, Carsten, Jeppesen, Nina, Langer, Seppo W.
Published in Acta oncologica (02.12.2023)

Get full text

Journal Article

A randomized phase II trial of concurrent chemoradiation with two doses of radiotherapy, 60 Gy and 66 Gy, concomitant with a fixed dose of oral vinorelbine in locally advanced NSCLC

A randomized phase II trial of concurrent chemoradiation with two doses of radiotherapy, 60 Gy and 66 Gy, concomitant with a fixed dose of oral vinorelbine in locally advanced NSCLC

by Hansen, Olfred, Knap, Marianne M, Khalil, Azza, Nyhus, Christa H, McCulloch, Tine, Holm, Bente, Brink, Carsten, Hoffmann, Lone, Schytte, Tine
Published in Radiotherapy and oncology (01.05.2017)

Get full text

Journal Article

EGFR mutation frequency and effectiveness of erlotinib: A prospective observational study in Danish patients with non-small cell lung cancer

EGFR mutation frequency and effectiveness of erlotinib: A prospective observational study in Danish patients with non-small cell lung cancer

by Weber, Britta, Hager, Henrik, Sorensen, Boe S, McCulloch, Tine, Mellemgaard, Anders, Khalil, Azza Ahmed, Nexo, Ebba, Meldgaard, Peter
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2014)

Get full text

Journal Article

Acute esophagitis for patients with local–regional advanced non small cell lung cancer treated with concurrent chemoradiotherapy

Acute esophagitis for patients with local–regional advanced non small cell lung cancer treated with concurrent chemoradiotherapy

by Pan, Yi, Brink, Carsten, Knap, Marianne, Khalil, Azza A, Nyhus, Christa H, McCulloch, Tine, Holm, Bente, Wu, Yi-long, Schytte, Tine, Hansen, Olfred
Published in Radiotherapy and oncology (01.03.2016)

Get full text

Journal Article

A randomized phase II trial of concurrent chemoradiation with two doses of radiotherapy, 60Gy and 66Gy, concomitant with a fixed dose of oral vinorelbine in locally advanced NSCLC

A randomized phase II trial of concurrent chemoradiation with two doses of radiotherapy, 60Gy and 66Gy, concomitant with a fixed dose of oral vinorelbine in locally advanced NSCLC

by Hansen, Olfred, Knap, Marianne M., Khalil, Azza, Nyhus, Christa H., McCulloch, Tine, Holm, Bente, Brink, Carsten, Hoffmann, Lone, Schytte, Tine
Published in Radiotherapy and oncology (01.05.2017)

Get full text

Journal Article

P2.02-049 Gender and Risk of Cessation of Oral Vinorelbine in a Randomized Trial of Concurrent Chemoradiation of Locally Advanced NSCLC: Topic: Prognostic Factor

P2.02-049 Gender and Risk of Cessation of Oral Vinorelbine in a Randomized Trial of Concurrent Chemoradiation of Locally Advanced NSCLC: Topic: Prognostic Factor

by Hansen, Olfred, Schytte, Tine, Knap, Marianne, Khalil, Azza, Nyhus, Christa, Mcculloch, Tine, Holm, Bente, Andersen, Jon, Møller, Ditte, Nielsen, Tine, Hoffmann, Lone, Brink, Carsten
Published in Journal of thoracic oncology (01.01.2017)

Get full text

Journal Article

P2.02-049 Gender and Risk of Cessation of Oral Vinorelbine in a Randomized Trial of Concurrent Chemoradiation of Locally Advanced NSCLC

P2.02-049 Gender and Risk of Cessation of Oral Vinorelbine in a Randomized Trial of Concurrent Chemoradiation of Locally Advanced NSCLC

by Hansen, Olfred, Schytte, Tine, Knap, Marianne, Khalil, Azza, Nyhus, Christa, Mcculloch, Tine, Holm, Bente, Andersen, Jon, Møller, Ditte, Nielsen, Tine, Hoffmann, Lone, Brink, Carsten
Published in Journal of thoracic oncology (01.01.2017)

Get full text

Journal Article

A randomized phase II trial of concurrent chemoradiation of oral vinorelbine and two doses of radiotherapy, 60 and 66 Gy, in local-regionally advanced non-small cell lung cancer (LA-NSCLC)

A randomized phase II trial of concurrent chemoradiation of oral vinorelbine and two doses of radiotherapy, 60 and 66 Gy, in local-regionally advanced non-small cell lung cancer (LA-NSCLC)

by Hansen, Olfred, Knap, Marianne, Khalil, Azza, Nyhus, Christa Haugaard, McCulloch, Tine, Holm, Bente, Brink, Carsten, Hoffmann, Lone, Schytte, Tine
Published in Journal of clinical oncology (20.05.2014)

Get full text

Journal Article

Randomized phase III trial in extensive-disease small cell lung cancer comparing first-line etoposide to topotecan in combination with platinum

Randomized phase III trial in extensive-disease small cell lung cancer comparing first-line etoposide to topotecan in combination with platinum

by Mau-Soerensen, Morten, Hansen, Olfred, Holm, Bente, Nyhus, Christa Haugaard, McCulloch, Tine, Nielsen, Henrik Anker, Wedervang, Kim, Rytter, Carsten, Jeppesen, Nina, Langer, Seppo
Published in Journal of clinical oncology (20.05.2014)

Get full text

Journal Article

Effective ultra-low doses of erlotinib in patients with EGFR sensitising mutation

Effective ultra-low doses of erlotinib in patients with EGFR sensitising mutation

by Szejniuk, Weronika Maria, McCulloch, Tine, Røe, Oluf Dimitri
Published in BMJ case reports (23.07.2014)

Get full text

Journal Article

A phase II study using vinorelbine and continuous 5-fluorouracil in patients with advanced head and neck cancer

A phase II study using vinorelbine and continuous 5-fluorouracil in patients with advanced head and neck cancer

by Larsen, Susanne, Serup-Hansen, Eva, Andersen, Lisbeth J., Lindeløv, Birgit, McCulloch, Tine, Adimi, Parvin, Bastholt, Lars
Published in Acta oncologica (2007)

Get full text

Journal Article

Effective ultra-low doses of erlotinib in patients with EGFR sensitising mutation

Effective ultra-low doses of erlotinib in patients with EGFR sensitising mutation

by Szejniuk, Weronika Maria, McCulloch, Tine, Røe, Oluf Dimitri
Published in BMJ Case Reports (23.07.2014)

Get full text

Report